Mark Turner

Has grant

Professor of Neonatology and Research Delivery

University of Liverpool

United Kingdom

Research Interests

Explore related searches

Professors in United Kingdom

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Mark Turner is a Professor of Neonatology and Research Delivery at the University of Liverpool, UK. His research areas include pediatric clinical trials, drug development for children, and the assessment of analgesic efficacy in neonates. He has published recent articles addressing the design and delivery of pediatric trials, the future of neonatology, and data standards in health, contributing to advancements in clinical practices for neonatal care.

Recent Grants

Grant: Close

Advancing standards and methodologies to generate real world evidence from real world data through a neonatal pilot project

Open Date: 2021-05-01

Close Date: 2024-04-01

Grant: Close

European Joint Programme on Rare Diseases

Open Date: 2019-01-01

Close Date: 2023-12-01

Grant: Close

c4c

Open Date: 2018-05-01

Close Date: 2024-04-01

Grant: Close

A randomized trial comparing oral misoprostol alone with oral misoprostol followed by oxytocin in women induced forhypertension of pregnancy

Open Date: 2018-04-01

Close Date: 2022-04-01

Grant: Close

The efficacy and mechanism of surfactant therapy in infants with life threatening Bronchiolitis: the Bronchiolitis Endotracheal Surfactant Study (BESS).

Open Date: 2018-02-01

Close Date:

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (13)

Nicola Jayne Robertson

University College London

UNITED KINGDOM

View details

Joseph Standing

University College London

UNITED KINGDOM

View details

karel allegaert

Erasmus University Rotterdam

NETHERLANDS

View details

Atholl Johnston

Professor of Clinical Pharmacology

Barts and The London School of Medicine and Dentistry

UNITED KINGDOM

View details

Karin Kipper

Head of Therapeutic Drug Monitoring Unit

UNITED KINGDOM

View details

Mandy Wan

King’s College London

UNITED KINGDOM

View details

Jan Janota

Head of Neonatal Unit

University Hospital in Motol

CZECH REPUBLIC

View details

Catherine Tuleu

UCL School of Pharmacy

UNITED KINGDOM

View details

Charlotte Barker

University College London

UNITED KINGDOM

View details

Heike Rabe

Professor

UNITED KINGDOM

View details

Lars Naver

Karolinska Institutet

SWEDEN

View details

Eleanor molloy

Chair and Professor of Paediatrics

Trinity College Dublin

IRELAND

View details

Claudia Pansieri

Istituto di Ricerche Farmacologiche Mario Negri

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mark Turner

Research Interests

Explore related searches

Contact this professor

About

Recent Grants

Articles (20)

Experience and lessons learned relating to investigational product supply in the design and delivery of a paediatric investigator-initiated clinical trial

“Common sense is hard work” but benefits from persistent collaboration: Lessons learnt from the development of The Collaborative Network for European Clinical Trials for Children (c4c) to support the conduct of paediatric clinical trials of medicines

The Lancet Child &amp; Adolescent Health Commission on the future of neonatology

Consideration for Assessing Data/Models/Tools Expiration Supporting Drug Development and Clinical Decision Making

Is noxious stimulus-evoked electroencephalography response a reliable, valid, and interpretable outcome measure to assess analgesic efficacy in neonates? A systematic review and individual participant data (IPD) meta-analysis protocol.

Paediatric-specific content in data standards for health

Feasibility and acceptability of randomized controlled trial of intervention vs expectant management for early-onset selective fetal growth restriction in monochorionic twin pregnancy.

Better Medicines for Children: Lessons Learnt and Share Learnings at the EFGCP Annual Paediatric Conferences.

Developing and streamlining clinical trial services to support pediatric drug development across 21 countries in Europe: insights from the conect4children (c4c) network.

Mapping the rare disease paediatric clinical trial availabilities in Europe.

The Neonatal and Paediatric Pharmacokinetics of Antimicrobials study (NAPPA): investigating amoxicillin, benzylpenicillin, flucloxacillin and piperacillin pharmacokinetics from birth to adolescence

The publication quality of laboratory values in clinical studies in neonates

Neonatal sepsis: a systematic review of core outcomes from randomised clinical trials

Assessing patent ductus arteriosus in preterm infants from standard neonatal intensive care monitoring

Development and evaluation of an assessment of the age-appropriateness/inappropriateness of formulations used in children

Health Equity in Pediatric Drug Development: Translating Aspiration into Operation

European research networks to facilitate drug research in children

WHO essential medicines for children 2011–2019: age-appropriateness of enteral formulations

From Paediatric Formulations Development to Access: Advances Made and Remaining Challenges.

Developing a More Tailored Approach to Patient and Public Involvement with Children and Families in Pediatric Clinical Research: Lessons Learned.

Collaborators (13)

Nicola Jayne Robertson

Joseph Standing

karel allegaert

Atholl Johnston

Karin Kipper

Mandy Wan

Jan Janota

Catherine Tuleu

Charlotte Barker

Heike Rabe

Lars Naver

Eleanor molloy

Claudia Pansieri

Make your next move.

The Lancet Child & Adolescent Health Commission on the future of neonatology